Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP122525.RAEeJwMLfuYRSnL-6TuYb86PvtHpsmNQGtasQMuUa8xG8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP122525.RAEeJwMLfuYRSnL-6TuYb86PvtHpsmNQGtasQMuUa8xG8130_assertion type Assertion NP122525.RAEeJwMLfuYRSnL-6TuYb86PvtHpsmNQGtasQMuUa8xG8130_head.
- NP122525.RAEeJwMLfuYRSnL-6TuYb86PvtHpsmNQGtasQMuUa8xG8130_assertion description "[T. cruzi-infected individuals who are heterozygous for the MAL/TIRAP S180L variant that leads to a decrease in signal transduction upon ligation of TLR2 or TLR4 to their respective ligand may have a lower risk of developing CCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP122525.RAEeJwMLfuYRSnL-6TuYb86PvtHpsmNQGtasQMuUa8xG8130_provenance.
- NP122525.RAEeJwMLfuYRSnL-6TuYb86PvtHpsmNQGtasQMuUa8xG8130_assertion evidence source_evidence_literature NP122525.RAEeJwMLfuYRSnL-6TuYb86PvtHpsmNQGtasQMuUa8xG8130_provenance.
- NP122525.RAEeJwMLfuYRSnL-6TuYb86PvtHpsmNQGtasQMuUa8xG8130_assertion SIO_000772 19456234 NP122525.RAEeJwMLfuYRSnL-6TuYb86PvtHpsmNQGtasQMuUa8xG8130_provenance.
- NP122525.RAEeJwMLfuYRSnL-6TuYb86PvtHpsmNQGtasQMuUa8xG8130_assertion wasDerivedFrom gad-20150221 NP122525.RAEeJwMLfuYRSnL-6TuYb86PvtHpsmNQGtasQMuUa8xG8130_provenance.
- NP122525.RAEeJwMLfuYRSnL-6TuYb86PvtHpsmNQGtasQMuUa8xG8130_assertion wasGeneratedBy ECO_0000203 NP122525.RAEeJwMLfuYRSnL-6TuYb86PvtHpsmNQGtasQMuUa8xG8130_provenance.